These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4748873)

  • 1. Interdisciplinary session report. Obstacles to routine transfusion support of myelosuppressive patients.
    Henderson ES; Graw RG; Anderson RM; Yankee RA; Opelz G; Lalezari P; Meryman HT
    Cancer Chemother Rep 3; 1973 May; 4(3):51-9. PubMed ID: 4748873
    [No Abstract]   [Full Text] [Related]  

  • 2. [Avoidance of transfusion reactions by the use of largely leukocyte- and thrombocyte-free erythrocyte extracts].
    Marcard E; Spiess HG
    Bibl Haematol; 1971; 37():194-8. PubMed ID: 5158186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-leukocyte and anti-platelet immunization and transfusions during aplastic anemias].
    Dausset J; Benbunan M
    Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):132-43. PubMed ID: 781619
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged granulocytopenia from incompatible platelet transfusions.
    Herzig RH; Poplack DG; Yankee RA
    N Engl J Med; 1974 May; 290(22):1220-3. PubMed ID: 4825852
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in platelet transfusion].
    Kummer H
    Ther Umsch; 1973 Nov; 30(11):797-801. PubMed ID: 4585652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of leukocyte groups in transplantation serology].
    van Rood JJ
    Bibl Haematol; 1971; 37():53-69. PubMed ID: 4109677
    [No Abstract]   [Full Text] [Related]  

  • 7. HL-A in connection with blood transfusion.
    Engelfriet CP; van Loghem JJ
    Haematologia (Budap); 1974; 8(1-4):267-72. PubMed ID: 4618231
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(12):821-3. PubMed ID: 6762620
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complications in blood transfusion].
    Höglund S
    Lakartidningen; 1972 Dec; 69():Suppl 4:65-72. PubMed ID: 4656852
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transfusion therapy with thrombocytes].
    Seidl S
    Z Prakt Anasth; 1970 Aug; 5(4):252-9. PubMed ID: 4256234
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the development of bone marrow hypoplasia. II. Effects of anti-leukocyte antibodies on blood and bone marrow.
    Das KC; Aikat BK
    Indian J Med Res; 1969 Apr; 57(4):670-87. PubMed ID: 5306672
    [No Abstract]   [Full Text] [Related]  

  • 12. [Replacement therapy in bone marrow insufficiencies].
    Splinter AW
    Ned Tijdschr Geneeskd; 1977 Jun; 121(26):1061-6. PubMed ID: 329152
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow failure: current concepts of pathophysiology and management.
    Epstein RB
    Surg Annu; 1978; 10():53-72. PubMed ID: 416509
    [No Abstract]   [Full Text] [Related]  

  • 14. Scientific advances in transfusion.
    O'Riordan JP
    J Ir Med Assoc; 1973 Jan; 66(2):27-36. PubMed ID: 4569809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Granulocyte and thrombocyte substitution].
    Höcker P; Pittermann E; Mann M; Krasa E; Blumauer H
    Infusionsther Klin Ernahr; 1980 Aug; 7(4):197-203. PubMed ID: 7191415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typing for the MLC determinants and its possible impact on Europdonor.
    van Rood JJ; van Leeuwen A; van den Tweel JG; Blussé van Oud Alblas A; Keuning JJ; Eernisse JG
    Transplant Proc; 1974 Dec; 6(4):411-5. PubMed ID: 4140594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survival rate studies on compatible and incompatible thrombocytes in patients with severe thrombocytopenia].
    Adam W; Marcard E; Erdmann H; Kratt E
    Bibl Haematol; 1971; 37():89-97. PubMed ID: 5138930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allo-immunisation against leucocyte, thrombocyte and tissue antigens caused by transfusion (author's transl)].
    Heiss F; Goldmann SF; Scheinert I
    Munch Med Wochenschr; 1973 Nov; 115(44):1974-8. PubMed ID: 4801764
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
    Eernisse JG; Brand A
    Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Unresponsiveness to platelets. A case study.
    Pegels JG; Bruynes EC; Korthals Altes HR; Engelfriet CP; von dem Borne AE
    Vox Sang; 1982; 42(4):211-6. PubMed ID: 7046248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.